Targeting LIF/lifr in pancreatic cancer
Ended Project Grant Awarded Last action
- Award ID
- R44CA235991
- Recipient
-
Evestra, Inc. UEI JDELV4PXM7Z3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,636,788
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Funding
-
- $2,680,716.00 Federal
- $956,072.00 Non-federal
- Place of performance
- San Antonio, TX 78245, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $956,072 | $0 | |
| Amendment | $956,072 | $956,072 | |
| Amendment | $614,006 | $0 | |
| Amendment | $0 | $0 | |
| Original award | $154,566 | $0 |
Quick answers
Who received award R44CA235991?
R44CA235991 was awarded to Evestra, Inc. by National Cancer Institute (National Institutes of Health) on April 2, 2019.
How much is award R44CA235991 worth?
$3,636,788 has been obligated on R44CA235991: $2,680,716 in federal funding and $956,072 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award